MEDINET Narrows Losses on Modest Sales Growth but Keeps Dividend at Zero

The latest update is out from MEDINET Co., Ltd. ( (JP:2370) ).

MEDINET Co., Ltd. reported net sales of ¥414 million for the six months ended March 2026, a 2.3% year-on-year increase, while operating and ordinary losses narrowed to ¥629 million and ¥516 million, respectively, resulting in a net loss of ¥551 million. Total assets declined to ¥3,987 million and net assets to ¥3,574 million, though the capital adequacy ratio remained high at 89.4%, and the company maintained a zero dividend for the second quarter, underscoring a continued emphasis on capital preservation amid gradual revenue growth but persistent losses.

More about MEDINET Co., Ltd.

MEDINET Co., Ltd., listed on the Tokyo Stock Exchange Growth market under securities code 2370, operates in the general business category in Japan. The company provides medical-related services and solutions, with a focus on stable capital structure, as reflected in its high equity ratio and solid net asset base despite ongoing losses.

Average Trading Volume: 1,887,376

Technical Sentiment Signal: Strong Sell

Current Market Cap: Yen7.81B

Learn more about 2370 stock on TipRanks’ Stock Analysis page.